Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Diseases
×
zipalertinib
×
Thoracic
×
Clear all
Filters
3
NCT05973773
2026-03-10
REZILIENT3
Taiho Oncology, Inc.
Phase 3
Active not recruiting
285 enrolled